Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Linking Three Proteins to Parkinson's

    Linking Three Proteins to Parkinson's

    A new study, funded in part by The Michael J. Fox Foundation (MJFF), recently identified a genetic-related pathway in PD.
    Learn more
  • Ballet and Brain Scans: A Parkinson's Research Project in Perfect Harmony

    Ballet and Brain Scans: A Parkinson's Research Project in Perfect Harmony

    Watch a documentary short that showcases the 'Dancing with Parkinson's' program to learn how dance can affect the brains of people with Parkinson's.
    Learn more
  • Researching a Better Way to Diagnose Parkinson's Disease

    Researching a Better Way to Diagnose Parkinson's Disease

    Joann, a person living with Parkinson's, shares her experience participating in the Systemic Synuclein Sampling Study (S4).
    Learn more
  • New Dyskinesia Drug Advances to Final Stage of FDA Review Process

    New Dyskinesia Drug Advances to Final Stage of FDA Review Process

    The FDA recently agreed to review the New Drug Application for a dyskinesia medication developed by Adamas Pharmaceuticals.
    Learn more
  • What to Ask before Enrolling in a Research Study

    What to Ask before Enrolling in a Research Study

    Read sample questions potential clinical trial volunteers should ask a trial team before deciding to enroll in a research study.
    Learn more
  • MJFF's Targeted Social Strategy Accelerates Research Participation

    MJFF's Targeted Social Strategy Accelerates Research Participation

    The success of MJFF's targeted Facebook recruitment program for PPMI was highlighted in the news.
    Learn more
  • Another Leap Forward for LRRK2 Development

    Another Leap Forward for LRRK2 Development

    With confidence from MJFF-led studies, Denali Therapeutics today announced it has licensed LRRK2 inhibitor compounds from Genentech.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.